Evidence map›Paper›PMID 36774538›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity.

Aaron M Frutos, Guillermina Kuan, Roger Lopez, Sergio Ojeda, Abigail Shotwell, Nery Sanchez, Saira Saborio, Miguel Plazaola, Carlos Barilla, Eben Kenah and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Aaron M FrutosDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Guillermina KuanHealth Center Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua.
Roger LopezSustainable Sciences Institute, Managua, Nicaragua.
Sergio OjedaSustainable Sciences Institute, Managua, Nicaragua.
Abigail ShotwellDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Nery SanchezSustainable Sciences Institute, Managua, Nicaragua.
Saira SaborioLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Miguel PlazaolaSustainable Sciences Institute, Managua, Nicaragua.
Carlos BarillaSustainable Sciences Institute, Managua, Nicaragua.
Eben KenahBiostatistics Division, College of Public Health, The Ohio State University, Columbus, Ohio, USA.
Angel BalmasedaSustainable Sciences Institute, Managua, Nicaragua.
Aubree GordonDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-9352-7877
Sustainable Sciences Institute · USNational Autonomous University of Nicaragua · NIUniversity of Michigan · USThe Ohio State University · US

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7M
Flu Dynamics COVID-19 SupplementR01AI120997 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GORDON, AUBREE L · 2017 to 2021
$4.1M
NIAID NIH HHS 75N93021C00016NIAID NIH HHS HHSN272201400006CNIAID NIH HHS R01 AI120997NIAID NIH HHS U01 AI144616NIH HHS
6 · The paper itself

Abstract

backgroundThe impact of infection-induced immunity on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has not been well established. Here we estimate the effects of prior infection induced immunity in adults and children on SARS-CoV-2 transmission in households.

methodsWe conducted a household cohort study from March 2020-November 2022 in Managua, Nicaragua; following a housheold SARS-CoV-2 infection, household members are closely monitored for infection. We estimate the association of time period, age, symptoms, and prior infection with secondary attack risk.

resultsOverall, transmission occurred in 70.2% of households, 40.9% of household contacts were infected, and the secondary attack risk ranged from 8.1% to 13.9% depending on the time period. Symptomatic infected individuals were more infectious (rate ratio [RR] 21.2, 95% confidence interval [CI]: 7.4-60.7) and participants with a prior infection were half as likely to be infected compared to naïve individuals (RR 0.52, 95% CI:.38-.70). In models stratified by age, prior infection was associated with decreased infectivity in adults and adolescents (secondary attack risk [SAR] 12.3, 95% CI: 10.3, 14.8 vs 17.5, 95% CI: 14.8, 20.7). However, although young children were less likely to transmit, neither prior infection nor symptom presentation was associated with infectivity. During the Omicron era, infection-induced immunity remained protective against infection.

conclusionsInfection-induced immunity is associated with decreased infectivity for adults and adolescents. Although young children are less infectious, prior infection and asymptomatic presentation did not reduce their infectivity as was seen in adults. As SARS-CoV-2 transitions to endemicity, children may become more important in transmission dynamics.

Indexed as

COVID-19AdolescentAdultChildChild, PreschoolCohort StudiesFamily CharacteristicsHumansNicaraguaSARS-CoV-2cohort studyCOVID-19SARS-CoV-2secondary attack ratetransmission

Identifiers

PMID36774538
PMCPMC10273383
OpenAlexW4320041388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.